• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白:肾结石形成过程中的一种重要蛋白质。

Osteopontin: An important protein in the formation of kidney stones.

作者信息

Jia Qingxia, Huang Ziye, Wang Guang, Sun Xia, Wu Yuyun, Yang Bowei, Yang Tongxin, Liu Jianhe, Li Pei, Li Jiongming

机构信息

The Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China.

出版信息

Front Pharmacol. 2022 Nov 9;13:1036423. doi: 10.3389/fphar.2022.1036423. eCollection 2022.

DOI:10.3389/fphar.2022.1036423
PMID:36452224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9703462/
Abstract

The incidence of kidney stones averages 10%, and the recurrence rate of kidney stones is approximately 10% at 1 year, 35% at 5 years, 50% at 10 years, and 75% at 20 years. However, there is currently a lack of good medicines for the prevention and treatment of kidney stones. Osteopontin (OPN) is an important protein in kidney stone formation, but its role is controversial, with some studies suggesting that it inhibits stone formation, while other studies suggest that it can promote stone formation. OPN is a highly phosphorylated protein, and with the deepening of research, there is growing evidence that it promotes stone formation, and the phosphorylated protein is believed to have adhesion effect, promote stone aggregation and nucleation. In addition, OPN is closely related to immune cell infiltration, such as OPN as a pro-inflammatory factor, which can activate mast cells (degranulate to release various inflammatory factors), macrophages (differentiated into M1 macrophages), and T cells (differentiated into T1 cells) etc., and these inflammatory cells play a role in kidney damage and stone formation. In short, OPN mainly exists in the phosphorylated form in kidney stones, plays an important role in the formation of stones, and may be an important target for drug therapy of kidney stones.

摘要

肾结石的发病率平均为10%,其复发率在1年时约为10%,5年时为35%,10年时为50%,20年时为75%。然而,目前缺乏防治肾结石的有效药物。骨桥蛋白(OPN)是肾结石形成过程中的一种重要蛋白质,但其作用存在争议,一些研究表明它能抑制结石形成,而另一些研究则表明它可促进结石形成。OPN是一种高度磷酸化的蛋白质,随着研究的深入,越来越多的证据表明它促进结石形成,且磷酸化蛋白被认为具有黏附作用,可促进结石聚集和成核。此外,OPN与免疫细胞浸润密切相关,例如OPN作为一种促炎因子,可激活肥大细胞(脱颗粒释放各种炎症因子)、巨噬细胞(分化为M1巨噬细胞)和T细胞(分化为T1细胞)等,而这些炎症细胞在肾脏损伤和结石形成中发挥作用。简而言之,OPN在肾结石中主要以磷酸化形式存在,在结石形成中起重要作用,可能是肾结石药物治疗的重要靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fac/9703462/fac76f98e918/fphar-13-1036423-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fac/9703462/350ff1c282be/fphar-13-1036423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fac/9703462/fac76f98e918/fphar-13-1036423-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fac/9703462/350ff1c282be/fphar-13-1036423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fac/9703462/fac76f98e918/fphar-13-1036423-g002.jpg

相似文献

1
Osteopontin: An important protein in the formation of kidney stones.骨桥蛋白:肾结石形成过程中的一种重要蛋白质。
Front Pharmacol. 2022 Nov 9;13:1036423. doi: 10.3389/fphar.2022.1036423. eCollection 2022.
2
The osteopontin-controlled switching of calcium oxalate monohydrate morphologies in artificial urine provides insights into the formation of papillary kidney stones.在人工尿液中,骨桥蛋白控制一水草酸钙单水合物形态的转变,为研究乳头状肾结石的形成提供了思路。
Colloids Surf B Biointerfaces. 2016 Oct 1;146:296-306. doi: 10.1016/j.colsurfb.2016.06.030. Epub 2016 Jun 16.
3
Expression, roles, receptors, and regulation of osteopontin in the kidney.骨桥蛋白在肾脏中的表达、作用、受体及调控
Kidney Int. 2001 Nov;60(5):1645-57. doi: 10.1046/j.1523-1755.2001.00032.x.
4
Osteopontin and calcium stone formation.骨桥蛋白与钙结石形成。
Nephron Physiol. 2004;98(2):p43-7. doi: 10.1159/000080263.
5
The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells.骨桥蛋白对草酸钙晶体与犬肾细胞黏附的影响。
Eur Urol. 1996;30(3):388-93. doi: 10.1159/000474201.
6
Quantification of osteopontin in the urine of healthy and stone-forming men.健康男性和结石形成男性尿液中骨桥蛋白的定量分析。
Urol Res. 1999 Aug;27(4):225-30. doi: 10.1007/s002400050114.
7
Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney.草酸钙晶体向结石的形态转化受小鼠肾脏中骨桥蛋白的调控。
J Bone Miner Res. 2008 Oct;23(10):1629-37. doi: 10.1359/jbmr.080514.
8
Calcium phosphate stones produced by Madin-Darby canine kidney (MDCK) cells inoculated in nude mice.接种于裸鼠体内的麦迪逊-达比犬肾(MDCK)细胞产生的磷酸钙结石。
Urol Res. 1999 Jun;27(3):200-5. doi: 10.1007/s002400050110.
9
Aprt/Opn double knockout mice: osteopontin is a modifier of kidney stone disease severity.Aprt/Opn双敲除小鼠:骨桥蛋白是肾结石疾病严重程度的一个调节因子。
Kidney Int. 2005 Sep;68(3):938-47. doi: 10.1111/j.1523-1755.2005.00487.x.
10
Modulation of calcium oxalate dihydrate growth by phosphorylated osteopontin peptides.磷酸化骨桥蛋白肽对二水草酸钙生长的调控。
J Struct Biol. 2018 Nov;204(2):131-144. doi: 10.1016/j.jsb.2018.07.010. Epub 2018 Jul 17.

引用本文的文献

1
Correlation Between Urinary Osteopontin Concentration and the Mineral Content and Composition of Kidney Stones.尿骨桥蛋白浓度与肾结石矿物质含量及组成的相关性
J Clin Med. 2025 Sep 4;14(17):6247. doi: 10.3390/jcm14176247.
2
Association between rheumatoid arthritis and kidney stones: A cross-sectional study of NHANES 2007-2020.类风湿关节炎与肾结石之间的关联:一项基于2007 - 2020年美国国家健康与营养检查调查(NHANES)的横断面研究。
Arthritis Res Ther. 2025 Jul 9;27(1):141. doi: 10.1186/s13075-025-03604-w.
3
Targeting the NLRP3 inflammasome for calcium oxalate stones: pathophysiology and emerging pharmacological interventions.

本文引用的文献

1
Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKD.骨桥蛋白调节磷酸盐溶解度以预防慢性肾脏病中的矿物质聚集。
Kidney360. 2022 Sep 29;3(9):1477-1479. doi: 10.34067/KID.0004292022.
2
Gallic acid ameliorates calcium oxalate crystal-induced renal injury via upregulation of Nrf2/HO-1 in the mouse model of stone formation.没食子酸通过上调 Nrf2/HO-1 减轻草酸钙晶体诱导的肾损伤在结石形成的小鼠模型中。
Phytomedicine. 2022 Nov;106:154429. doi: 10.1016/j.phymed.2022.154429. Epub 2022 Sep 5.
3
Mechanism of ketotifen fumarate inhibiting renal calcium oxalate stone formation in SD rats.
靶向NLRP3炎性小体治疗草酸钙结石:病理生理学及新兴的药理学干预措施
Front Physiol. 2025 Jun 3;16:1614438. doi: 10.3389/fphys.2025.1614438. eCollection 2025.
4
Regulating the balance between GSDMD-mediated pyroptosis and CHMP4B-dependent cell repair attenuates calcium oxalate kidney stone formation.调节Gasdermin D介导的细胞焦亡与Charged multivesicular body protein 4B依赖性细胞修复之间的平衡可减轻草酸钙肾结石的形成。
Int J Biol Sci. 2025 Apr 22;21(7):3099-3121. doi: 10.7150/ijbs.105415. eCollection 2025.
5
Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database.药物性肾结石:一项使用美国食品药品监督管理局不良事件报告系统数据库的真实世界药物警戒研究。
Front Pharmacol. 2025 Mar 27;16:1511115. doi: 10.3389/fphar.2025.1511115. eCollection 2025.
6
The immune duality of osteopontin and its therapeutic implications for kidney transplantation.骨桥蛋白的免疫双重性及其在肾移植中的治疗意义
Front Immunol. 2025 Feb 28;16:1520777. doi: 10.3389/fimmu.2025.1520777. eCollection 2025.
7
Molecular insights into cell signaling pathways in kidney stone formation.肾结石形成中细胞信号通路的分子见解。
Urolithiasis. 2025 Feb 14;53(1):30. doi: 10.1007/s00240-025-01702-7.
8
Advances in the mechanism of urinary proteins in calcium oxalate kidney stone formation.草酸钙肾结石形成过程中尿蛋白机制的研究进展
Urolithiasis. 2025 Feb 11;53(1):27. doi: 10.1007/s00240-025-01703-6.
9
Raman Spectroscopic Analysis of Molecular Structure and Mechanical Properties of Hypophosphatasia Primary Tooth.低磷酸酯酶症乳牙的分子结构与力学性能的拉曼光谱分析
Molecules. 2024 Dec 22;29(24):6049. doi: 10.3390/molecules29246049.
10
Identifying therapeutic targets for kidney stone disease through proteome-wide Mendelian randomization and colocalization analysis.通过全蛋白质组孟德尔随机化和共定位分析鉴定肾结石病的治疗靶点。
Urolithiasis. 2024 Nov 25;52(1):167. doi: 10.1007/s00240-024-01669-x.
富马酸酮替芬抑制 SD 大鼠肾草酸钙结石形成的机制。
Biomed Pharmacother. 2022 Jul;151:113147. doi: 10.1016/j.biopha.2022.113147. Epub 2022 May 25.
4
Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet.阿托伐他汀通过增强高脂饮食高草酸钙尿结石形成大鼠肾脏骨桥蛋白表达减少肾脏草酸钙结石沉积。
Int J Mol Sci. 2022 Mar 11;23(6):3048. doi: 10.3390/ijms23063048.
5
Adefovir accumulation in the renal interstitium triggers mast cell degranulation and promotes renal interstitial fibrosis.阿德福韦在肾间质中的蓄积会触发肥大细胞脱颗粒,并促进肾间质纤维化。
Toxicol Lett. 2022 Apr 15;359:10-21. doi: 10.1016/j.toxlet.2022.01.018. Epub 2022 Jan 31.
6
Deficiency of IKK in Macrophages Mitigates Fibrosis Progression in the Kidney after Renal Ischemia-Reperfusion Injury.巨噬细胞中 IKK 的缺乏减轻了肾缺血再灌注损伤后的肾脏纤维化进展。
J Immunol Res. 2021 Dec 7;2021:5521051. doi: 10.1155/2021/5521051. eCollection 2021.
7
HLA-G Is Widely Expressed by Mast Cells in Regions of Organ Fibrosis in the Liver, Lung and Kidney.HLA-G 在肝脏、肺和肾脏的器官纤维化区域广泛表达于肥大细胞。
Int J Mol Sci. 2021 Nov 19;22(22):12490. doi: 10.3390/ijms222212490.
8
Phosphorylated Osteopontin Secreted from Cancer Cells Induces Cancer Cell Motility.磷酸化骨桥蛋白由癌细胞分泌,诱导癌细胞迁移。
Biomolecules. 2021 Sep 7;11(9):1323. doi: 10.3390/biom11091323.
9
The Role of Macrophages in Kidney Fibrosis.巨噬细胞在肾纤维化中的作用。
Front Physiol. 2021 Aug 6;12:705838. doi: 10.3389/fphys.2021.705838. eCollection 2021.
10
Hydroxycitrate prevents calcium oxalate crystallization and kidney injury in a nephrolithiasis rat model.羟基柠檬酸可预防肾结石大鼠模型中的草酸钙结晶和肾损伤。
Urolithiasis. 2022 Feb;50(1):47-53. doi: 10.1007/s00240-021-01283-1. Epub 2021 Aug 19.